Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 19, 2022

SELL
$10.83 - $18.41 $409,374 - $695,898
-37,800 Closed
0 $0
Q2 2021

Jul 13, 2021

BUY
$16.52 - $20.4 $105,728 - $130,559
6,400 Added 20.38%
37,800 $649,000
Q4 2020

Feb 02, 2021

SELL
$15.77 - $19.03 $82,004 - $98,956
-5,200 Reduced 14.21%
31,400 $534,000
Q3 2020

Oct 28, 2020

BUY
$16.59 - $24.79 $384,888 - $575,128
23,200 Added 173.13%
36,600 $607,000
Q3 2020

Oct 27, 2020

SELL
$16.59 - $24.79 $472,815 - $706,515
-28,500 Reduced 68.02%
13,400 $244,000
Q1 2020

Jun 11, 2020

BUY
$14.47 - $27.96 $169,299 - $327,132
11,700 Added 38.74%
41,900 $748,000
Q4 2019

Feb 10, 2020

BUY
$15.87 - $23.12 $266,616 - $388,416
16,800 Added 125.37%
30,200 $652,000
Q3 2019

Nov 25, 2019

SELL
$16.91 - $36.27 $15,219 - $32,643
-900 Reduced 6.29%
13,400 $244,000
Q2 2019

Aug 06, 2019

SELL
$31.0 - $36.3 $3,100 - $3,629
-100 Reduced 0.69%
14,300 $509,000
Q3 2018

Nov 19, 2018

SELL
$46.46 - $68.49 $18,584 - $27,395
-400 Reduced 2.7%
14,400 $878,000
Q2 2018

Aug 01, 2018

SELL
$46.25 - $104.45 $27,750 - $62,670
-600 Reduced 3.9%
14,800 $723,000
Q1 2018

Apr 25, 2018

BUY
$57.4 - $108.44 $883,960 - $1.67 Million
15,400 New
15,400 $1.64 Million

Others Institutions Holding NKTR

About NEKTAR THERAPEUTICS


  • Ticker NKTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,404,992
  • Market Cap $127M
  • Description
  • Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...
More about NKTR
Track This Portfolio

Track New Mexico Educational Retirement Board Portfolio

Follow New Mexico Educational Retirement Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Mexico Educational Retirement Board, based on Form 13F filings with the SEC.

News

Stay updated on New Mexico Educational Retirement Board with notifications on news.